ONWARD Medical Announces First Implant in New Clinical Feasibility Study Evaluating ARC-IM System to Restore Mobility After Spinal Cord Injury

Trial StartARC-IM SystemPositive

AI Analysis

Summary

ONWARD Medical announced the first implant in the EIGER clinical feasibility study evaluating the ARC-IM System for restoring mobility in patients with spinal cord injury. The study marks a key milestone in the development of the investigational neurotechnology platform.

Clinical Trial Data

Phase

feasibility

Outcome Details

first implant in EIGER clinical feasibility study

Importance:5/10

Sentiment:

0.50

spinal cord injuryneurotechnologyclinical trialmedical deviceneuromodulation

Related Companies

$ONWRY

Read the original article

Published by GlobeNewswire Clinical Studies on September 3, 2026 5:30 AM

Read Original